Results 61 to 70 of about 555,884 (236)
Journal of Pharmaceutical Policy and Practice, 2020 The response to emergency public health challenges such as HIV, TB, and malaria has been successful in mobilising resources and scaling up treatment for communicable diseases.
Tamara Hafner +8 more
doaj +1 more source
Developing Predictive Molecular Maps of Human Disease through Community-based Modeling [PDF]
, 2011 The failure of biology to identify the molecular causes of disease has led to disappointment in the rate of development of new medicines. By combining the power of community-based modeling with broad access to large datasets on a platform that promotes ...
Christine Suver +10 more
core +2 more sources
Pediatric Blood &Cancer, EarlyView.Abstract Background A routine baseline echocardiogram is often obtained prior to anthracycline administration in children with cancer. The utility of baseline echocardiogram is unclear in patients with standard risk B‐cell acute lymphoblastic leukemia (SR B‐ALL) as their anthracycline cumulative dose is low.
Ziyad Alrajhi +4 more
wiley +1 more source
Access to Medicines and the Right to (Cultural) Life [PDF]
, 2010 Published version available from: http://www.ashgate.com/isbn/9780754677611This groundbreaking book is the first collection to investigate together the law, political science and ethical perspectives on the right and value of ...
Gibson, J
core
The rise of companies from emerging markets in global health governance: opportunities and challenges [PDF]
, 2014 The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies.
ANNE ROEMER-MAHLER +23 more
core +1 more source
Promising Trends in Access to Medicines [PDF]
Global Policy, 2012 AbstractIt is a vast understatement to say that the problem of access to medicines in developing countries is complex. Access is limited by a range of factors including inability to pay, a lack of infrastructure, and corruption in some countries. Surrounding and exacerbating these structural and technological problems is the layer of legal rights ...
Morin, Jean-Frédéric, Gold, Richard E.
openaire +3 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Although most malignant germ cell tumors (GCTs) are highly curable with cisplatin‐based therapy, options for patients with multiply relapsed/refractory disease remain limited. For this population, we report the first pediatric use of gemcitabine, docetaxel, melphalan, and carboplatin (GemDMC) as part of sequential cycles of high‐dose ...
Maria Frost +10 more
wiley +1 more source
Harnessing the power of artificial intelligence in diagnostic systems
Machine Learning: HealthArtificial intelligence (AI) and machine learning are poised to reshape medical diagnostics, yet their path to integration is marked by both promise and complexity.
J Dong, D Woo, Y Wang, R Matiru
doaj +1 more source
Access to Medicines: the Role of Intellectual property Law and Policy [PDF]
, 2012 Intellectual property (IP) policy is an important structural determinant of health. Patent policy influences the rate and direction of innovation for health, playing a positive or negative role depending on how it is shaped and implemented.
El Said, Mohammed, Kapczynski, Amy
core
Study protocol for a cluster-randomized controlled trial of an NCD access to medicines initative: Evaluation of Novartis Access in Kenya [PDF]
, 2016 INTRODUCTION: Novartis recently launched Novartis Access, an initiative to provide a basket of reduced price medicines for non-communicable diseases (NCDs) to be sold through the public and private nonprofit sectors in programme countries.
Ashigbie, Paul G. +5 more
core +1 more source